As a consequence, microbiota-derived butyrate, as a bridge between the intestinal environment and RA patients, can orchestrate autoantibody production in systemic lymphoid tissues by restoring Tfr/Tfh balance, therefore ameliorating RA. Here, TFRC is linked to rheumatoid arthritis.